Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More The Motley Fool 23:12 Sat, 24 Oct
CRISPR prime editing rewrites DNA in the human body for the first time Singularity Hub 3d DNA Biology Genetics All sources
Gene therapy offers to beat hepatitis B virus by muting its DNA The Hindu 4d Genetics DNA Global Health Article paywall All sources
Custom gene-Editing therapies for rare diseases could win faster approvals under FDA draft plan, not yet final Medical Daily 2d FDA Pennsylvania Biology
Casgevy gains UK label expansion for younger patient population Pharmaceutical Technology 2d Casgevy UK
